The Society of Behavioral Medicine (SBM) and the Society for Research on Nicotine and Tobacco (SRNT) are positioned to lead research so the public health benefits of 1-800-QUIT-NOW on cigarette packs can be monitored, evaluated, and maximized.
Tobacco use remains the world’s single largest cause of preventable disease, premature death, and avoidable health care costs. To reduce tobacco use, science-based leadership and research are needed to assess the benefits of 1-800-QUIT-NOW on cigarette packs.
The Society of Behavioral Medicine (SBM) and the Society for Research on Nicotine and Tobacco (SRNT) research communities ensure the June 2011 Food and Drug Administration (FDA) ruling on new cigarette package warning labels. These warning labels, which include graphic images and messages, also include quitline telephone numbers. Centers for Medicare and Medicaid Services (CMS) has announced that it will allow state Medicaid programs reimbursement for the delivery of evidence-based quitline counseling and operations costs at a 50 percent match rate.
If both the FDA and the CMS processes are implemented, research is required to address the impact of the 1-800-QUIT-NOW number and the increased coverage of state quitline services. Both the SBM and the SRNT are positioned to play a leading role in the development and execution of new research in these areas. SBM and SRNT urge policy-makers to ensure funding and leadership for research so the public health benefits of can be monitored, evaluated, and maximized.